| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Obstetrics and Gynecology (S.C.K., C.L.G., R.S.L.), Public Health Sciences (A.R.K.), Pathology (L.M.D.), and Pediatrics (P.A.L.), Penn State College of Medicine, Hershey, Pennsylvania 17033
Address all correspondence and requests for reprints to: Richard S. Legro, M.D., Department of Obstetrics and Gynecology, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033. E-mail: RSL1{at}psu.edu.
Objective: Hyperandrogenia and insulin resistance are heritable family traits, likely to cluster in children of polycystic ovary syndrome (PCOS) mothers.
Design: We performed a case control study of PCOS children (n = 32) compared with children from control women (n = 38) for reproductive and metabolic abnormalities, stratifying results by three Tanner stage groupings. The children underwent history and physical examinations, a 3-h timed urine collection, a 2-h oral glucose tolerance test, and abdominal ultrasound examination (females only). Serum was obtained in older children (age > 8 yr) who consented.
Results: Urine LH levels were significantly lower in the Tanner IV–V PCOS girls compared with controls (P = 0.04). Urine testosterone levels were significantly elevated in Tanner II–III PCOS boys compared with controls (P = 0.007). There were no significant differences in dehydroepiandrosterone levels. We validated the correlation between salivary and serum levels of insulin (insulin areas under the curve) in an adult population [n =30, Pearson correlation coefficient (r) = 0.67; P < 0.0001], which also replicated in the children (2-h insulin r = 0.57; P = 0.0004). Mean area under the curve salivary insulin levels were significantly higher in the Tanner IV–V PCOS girls in the later stages of puberty when compared with controls (3625 ± 1372 vs. 1766 ± 621 min x µU/ml, 95% confidence interval 475-3242; P < 0.02).
Conclusions: Hyperinsulinism may be a familial characteristic of PCOS children (or at least girls) but does not appear until the later stages of puberty. Other reproductive abnormalities that characterize PCOS may develop later.
This article has been cited by other articles:
![]() |
V. Padmanabhan Polycystic Ovary Syndrome -- "A Riddle Wrapped in a Mystery inside an Enigma" J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1883 - 1885. [Full Text] [PDF] |
||||
![]() |
T. Sir-Petermann, E. Codner, V. Perez, B. Echiburu, M. Maliqueo, A. Ladron de Guevara, J. Preisler, N. Crisosto, F. Sanchez, F. Cassorla, et al. Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hyperinsulinism in Daughters of Mothers with Polycystic Ovary Syndrome Journal Watch (General), August 28, 2008; 2008(828): 4 - 4. [Full Text] |
||||
![]() |
S. F. Witchel Ontogeny of Polycystic Ovary Syndrome: A Creative Approach J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1576 - 1578. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |